Formulation and Evaluation of Sintered Gastroretentive Tablets of Pioglitazone
The aim of the present study is to prepare sintered gastroretentive tablets of Pioglitazone and to study the effect of sintering on invitro dissolution study, hardness and friability. Sintering is defined as the process of compaction or formation of compact at a temperature below the melting point of solid constituent for the purpose of increasing its strength by bonding the particles together. EVA 1802, stearic acid, carnauba wax, and natural polymers like almond gum, xanthun gum, guar gum were used. The tablets were prepared by direct compression and wet granulation technique using PVP as binder and EVA, carnauba wax, stearic acid in different concentration of 10%, 15% were used in preparation. The prepared tablets were subjected to sintering at three different temperatures of 50, 60, 70°C for three different time periods of 1hr, 2hr, 3hrs in hot air oven. Precompression and post compression parameters were performed. Results showed that the release rate of the drug was inversely related to the sintering temperature and time of sintering. The optimum drug retardation occurred in the tablets at 70°C for 3hrs. increasing the temperature and time of exposure to a particular temperature often decreases the release rate of the drug. In addition, the hardness of the sintered tablets was increased with increasing sintering temperature and duration of sintering whereas friability of tablets was found to be decreased with increasing time. The optimized formulations F3(SA+CW+XG), F4(SA+CW+EVA) sintered at 70°C for 3hrs showed the maximum release of 70-80%. from the kinetic profile it shows that the drug release followed zero order and nonfickian diffusion mechanism. Thus, the formulations F3 and F4 was considered to be the best formulations among all the 6 formulations sintered at various temperature and various time periods. Hence it shows the suitability of EVA,SA,CW, natural polymers for preparing the sintered gastroretentive tablets of Pioglitazone.